missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Transferrin Receptor Monoclonal Antibody (10F11), Invitrogen™
Mouse Monoclonal Antibody
Brand: Invitrogen MA511441
This item is not returnable.
View return policy
Description
MA5-11441 reacts with human and mouse samples in IHC (P), FACS and Western blot applications. This antibody is not suitable for MCF-7 or NIH-3T3 cells in Western blot analysis.
Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Serum transferrin receptor (sTfR) is used as a means of detecting erythropoietin (EPO) misuse by athletes and as a diagnostic test for anemias resulting from a number of conditions including rheumatoid arthritis, pregnancy, irritable bowel syndrome and in HIV patients.Specifications
Transferrin Receptor | |
Monoclonal | |
Conc. Not Determined | |
tissue culture supernatant with 0.09% sodium azide | |
P02786, Q62351 | |
TFRC | |
500 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG2b |
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot | |
10F11 | |
Unconjugated | |
TFRC | |
2610028K12Rik; AI195355; AI426448; AU015758; CD antigen CD71; CD71; chicken transferrin receptor; E430033M20Rik; I79_000642; IMD46; mammary tumor virus receptor 1; Mtvr1; Mtvr-1; p90; sTfR; T9; TfR; tfR1; TFR2; TFRC; TR; transferrin receptor; transferrin receptor (p90, CD71); transferrin receptor 2; transferrin receptor protein 1; Transferrin receptor protein 1, serum form; Trfr | |
Mouse | |
RUO | |
22042, 7037 | |
4° C | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction